Who owns INCYTE CORP (INCY)? Elite investor 13F holders

9 tracked elite investors reported holding INCYTE CORP as of 2026-06-30, including Dodge & Cox Funds, Renaissance Technologies LLC, Sound Shore, Gotham Asset Management, GMO. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

9 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute graft-versus-host disease; ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Dodge & Cox FundsINCYTE CORPSHARE2026-06-302026-08-13 00:00:001355482475.00 USD11957326.000000SharesreduceOriginal filing
Renaissance Technologies LLCINCYTE CORPSHARE2026-06-302026-08-13 00:00:00398135284.00 USD3512132.000000SharesreduceOriginal filing
Sound ShoreINCYTE CORPSHARE2026-06-302026-08-12 00:00:0085895479.00 USD757723.000000SharesreduceOriginal filing
Gotham Asset ManagementINCYTE CORPSHARE2026-06-302026-08-14 00:00:0081567621.00 USD719545.000000SharesaddOriginal filing
GMOINCYTE CORPSHARE2026-06-302026-08-13 00:00:0036114682.00 USD318584.000000SharesreduceOriginal filing
Bridgewater AssociatesINCYTE CORPSHARE2026-06-302026-08-14 00:00:0019073160.00 USD168253.000000SharesaddOriginal filing
Tudor InvestmentINCYTE CORPSHARE2026-06-302026-08-14 00:00:001227462.00 USD10828.000000SharesaddOriginal filing
D.E. ShawINCYTE CORPSHARE2026-06-302026-08-14 00:00:00455254.00 USD4016.000000SharesbuyOriginal filing
Ancora Advisors / Ancora HoldingsINCYTE CORPSHARE2026-06-302026-08-14 00:00:0028340.00 USD250.000000SharesholdOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown